ovarian%20mass
OVARIAN MASS
Ovarian cysts are typically noted after clinical screening, or as a result of exam for a suspected pelvic mass, or an incidental finding in investigations done for other reasons.
Most ovarian masses manifest with few or mild nonspecific symptoms.
Ovarian masses in women of reproductive age are mostly benign but the risk of malignancy increases with age.
Ovarian cysts in the prepubertal patients especially after the first week of life are abnormal and likely to be neoplastic. In adolescent patients, majority of ovarian masses are functional cysts.

Introduction

  • Ovarian cysts in prepubertal patients especially after the first week of life are abnormal and likely to be neoplastic, prompt ultrasound (US) evaluation and referral are warranted 
  • In adolescent patients, majority of ovarian masses are functional cysts
    • The most common neoplastic ovarian tumor in this age group is benign cystic teratoma of the ovary
  • Ovarian mass in women of reproductive age is mostly benign but the risk of malignancy increases with age
    • In most adnexal masses, malignancy is found in only 7-13% of premenopausal and 8-45% of postmenopausal patients
    • Risk of malignancy for ovarian tumor in patients <45 years is <1 in 15 while in postmenopausal women, the figure is 50% at the time of laparotomy 

Signs and Symptoms

  • Most ovarian masses manifest with few or mild nonspecific symptoms
    • Common symptoms include abdominal distension, abdominal pain or discomfort, metrorrhagia, dyspareunia, infertility, lower abdominal pressure sensation and urinary or gastrointestinal (GI) symptoms
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
4 days ago
Early screening for gestational diabetes does not improve the composite perinatal outcomes in obese women, reveals a study.
Audrey Abella, 4 days ago
A novel, investigational vaginal pH regulator (VPR) – a nonhormonal, water-based, petroleum-free contraceptive vaginal gel – improved genitourinary (GU) side effects and sexual satisfaction in women who are at risk of pregnancy but are not aiming to conceive, interim findings from the phase III AMPOWER* trial show.
Pearl Toh, 21 May 2020
A levonorgestrel (LNG)-releasing intrauterine device (IUD) maintains high contraceptive efficacy up to 6 years, which is beyond the 5-year period it is currently approved for, according to data from the Mirena Extension Trial (MET) released during the ACOG 2020 Meeting.
12 Dec 2019
Rotavirus (RV) is highly contagious. Globally, 2 million children are hospitalized and more than 500,000 die annually from RV associated gastroenteritis. Therefore, vaccination is imperative for the prevention of RV infections.